Department of Pathology, Anatomy & Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA.
J Histochem Cytochem. 2020 Nov;68(11):733-746. doi: 10.1369/0022155420937370. Epub 2020 Jul 6.
Proteoglycans are rapidly emerging as versatile regulators of intracellular catabolic pathways. This is predominantly achieved via the non-canonical induction of autophagy, a fundamentally and evolutionarily conserved eukaryotic pathway necessary for maintaining organismal homeostasis. Autophagy facilitated by either decorin, a small leucine-rich proteoglycan, or perlecan, a basement membrane heparan sulfate proteoglycan, proceeds independently of ambient nutrient conditions. We found that soluble decorin evokes endothelial cell autophagy and breast carcinoma cell mitophagy by directly interacting with vascular endothelial growth factor receptor 2 (VEGFR2) or the Met receptor tyrosine kinase, respectively. Endorepellin, a soluble, proteolytic fragment of perlecan, induces autophagy and endoplasmic reticulum stress within the vasculature, downstream of VEGFR2. These potent matrix-derived cues transduce key biological information via receptor binding to converge upon a newly discovered nexus of core autophagic machinery comprised of Peg3 (paternally expressed gene 3) for autophagy or mitostatin for mitophagy. Here, we give a mechanistic overview of the nutrient-independent, proteoglycan-driven programs utilized for autophagic or mitophagic progression. We propose that catabolic control of cell behavior is an underlying basis for proteoglycan versatility and may provide novel therapeutic targets for the treatment of human disease.
蛋白聚糖迅速成为细胞内分解代谢途径的多功能调节剂。这主要是通过非典型的自噬诱导来实现的,自噬是一种基本的和进化上保守的真核途径,对于维持生物体的内稳态是必要的。无论是小富含亮氨酸的蛋白聚糖decorin,还是基底膜硫酸乙酰肝素蛋白聚糖perlecan,都能独立于环境营养条件促进自噬。我们发现,可溶性decorin 通过直接与血管内皮生长因子受体 2 (VEGFR2)或 Met 受体酪氨酸激酶相互作用,分别引发内皮细胞自噬和乳腺癌细胞线粒体自噬。内胶原,一种可溶的、蛋白水解片段的 perlecan,在 VEGFR2 下游诱导血管中的自噬和内质网应激。这些有效的基质衍生线索通过受体结合传递关键的生物学信息,汇聚到一个新发现的核心自噬机制的连接点,该连接点由自噬的 Peg3(父系表达基因 3)或线粒体自噬的 mitostatin 组成。在这里,我们对非营养依赖的、蛋白聚糖驱动的自噬或线粒体自噬进展程序进行了机制概述。我们提出,细胞行为的分解代谢控制是蛋白聚糖多功能性的基础,并可能为人类疾病的治疗提供新的治疗靶点。